Navigation Links
Pap Test Could Spot Some Ovarian Cancers, Study Finds
Date:1/9/2013

By Maureen Salamon
HealthDay Reporter

WEDNESDAY, Jan. 9 (HealthDay News) -- With no routine screening test currently available for uterine or ovarian cancer -- the latter of which is extremely lethal -- scientists have found promise in a new method that can detect both types using cervical fluid obtained during routine Pap tests.

A pilot study led by researchers at Johns Hopkins University's Kimmel Cancer Center, in Baltimore, reports that DNA analysis of cervical fluid detected 100 percent of uterine cancers and 41 percent of ovarian cancers in a small group of women, with no false-positive results.

"This initial proof-of-concept pilot study really laid the groundwork to move forward," said study author Dr. Luis Diaz, an associate professor of oncology. "So many [disease indicator] tests out there lead to ambiguous results, which lead to a lot of anxiety in patients and unnecessary diagnostic tests and costs. I think this test offers the possibility of not only being an effective cancer screening test, but also one we can do without increasing the cost of health care."

The study is published Jan. 9 in the journal Science Translational Medicine.

Since Pap tests were introduced in the 1940s, the incidence and death rate from cervical cancer -- the leading cause of cancer deaths among women a century ago -- have plummeted 75 percent, according to study background information. But deaths from ovarian and uterine cancers did not drop substantially in the same time period. More than 69,000 American women were diagnosed with these two gynecological cancers in 2012, with 15,000 expected to die of ovarian cancer and 8,000 of uterine (also called endometrial) cancer each year.

The new research relied on the so-called PapGene test, which sequences the genes of cancer-specific mutations involved in ovarian and endometrial cancers. "Simple anatomy" explains why cervical fluid may contain more cells shed from the uterus instead of the ovaries, Diaz said, because ovaries are located farther up the reproductive tract and cells must first pass through the fallopian tubes.

Diaz and his colleagues applied the PapGene test to samples from ovarian and endometrial cancers of about 20 women with each type at Johns Hopkins and three other institutions, detecting both early and late-stage disease in both cancers tested.

The test -- which is years away from being available clinically -- would cost less than $100 and perhaps substantially less in several years after more research has been completed, Diaz said, adding that he'd like follow-up studies to include hundreds of women.

Another expert said the findings are "exciting" and indicate that the test has potential.

"Ovarian cancer is really the cancer we have no way of screening for, and no early symptoms, so anything we can do to allow us to pick it up early is very exciting," said Dr. Diana Contreras, director of gynecologic oncology at Long Island Jewish Medical Center in New Hyde Park, N.Y. "And certainly a test that can be done easily and cheaply is very exciting."

Abnormal bleeding in postmenopausal women is one way uterine cancer can be detected before reaching advanced stages. But ovarian cancer typically presents with vague symptoms easily mistaken for other conditions, making early detection extremely difficult.

Therefore, even a screening test detecting ovarian cancer 40 percent of the time it's present -- especially with no false-positive results -- is superior to what's available, Diaz and Contreras said.

"I think this study says the test has potential," Contreras said. "We must move forward with finding an answer, because ovarian cancer is so deadly."

More information

The U.S. Department of Health and Human Services offers a Pap test fact sheet .

SOURCES: Luis Diaz, M.D., associate professor, oncology, Johns Hopkins Kimmel Cancer Center, Baltimore; Diana Contreras, M.D., director, gynecologic oncology, Long Island Jewish Medical Center, New Hyde Park, N.Y.; Jan. 9, 2013, Science Translational Medicine


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Red wine, fruit compound could help block fat cell formation
2. Pulse pressure elevation could presage cerebrovascular disease in Alzheimers patients
3. Report says new evidence could tip the balance in aspirin cancer prevention care
4. Climate Change Could Be Tough on Seniors Health: Study
5. Could Menthol Cigarettes Pose Even Higher Stroke Risk?
6. Online Tool Could Diagnose Autism Quickly, Developers Say
7. Codeine After Surgery Could Endanger Certain Kids: Study
8. BMC study shows diverting passengers to elevators could help reduce falls at Logan Airport
9. Discovery could help to develop drugs for organ transplant and cancer patients
10. Feelings of immaturity accompany alcohol misuse into adulthood; discovery could improve treatments
11. Saliva test could dramatically increase detection of oral cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Pap Test Could Spot Some Ovarian Cancers, Study Finds
(Date:10/13/2017)... ... ... While it’s often important to take certain medications during the night, finding ... identified a solution. , She developed a prototype for MOTION LIGHT-UP PILL BOX to ... the need to turn on a light when taking medication during the night, allowing ...
(Date:10/13/2017)... Vegas, Nevada (PRWEB) , ... October 13, 2017 , ... ... 7® Hemp CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD ... dose required and providing a CBD form that can be easily incorporated into liquid ...
(Date:10/13/2017)... ... 13, 2017 , ... Apple Rehab Shelton Lakes , which specializes in ... the facility as part of a disaster drill on October 3rd. , Apple Rehab ... City Emergency Manager, as well as the Connecticut Long Term Care Mutual Aid ...
(Date:10/13/2017)... ... ... Ellevate Network, the leading network for professional women, brought together some of ... their inaugural Summit in New York City in June. The event was livestreamed with ... 3 million. To watch the Mobilize Women video, click here . , ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... giving viewers the lowdown on sciatica in a new episode of "Success Files," ... on current events and innovation and investigates each subject in-depth with passion and ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... INDIANAPOLIS , Oct. 2, 2017  Eli Lilly ... its financial results for the third quarter of 2017 ... a conference call on that day with the investment ... performance. The conference call will begin at ... public can access a live webcast of the conference ...
(Date:10/2/2017)... Halo Labs announces the European launch of their new ... at MIBio 2017 in Cambridge, U.K on ... in biopharmaceutical samples with unprecedented speed and sensitivity while using far ... Membrane Imaging. ... particle analysis system ...
(Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, ... 2017 earnings conference call and webcast on Friday, November ... a.m. (EDT) and ending at approximately 8:30 a.m. (CDT) ... discussing the company,s 2017 financial performance and guidance for ... opportunities, initiatives to enhance operational performance, and long-range financial ...
Breaking Medicine Technology: